Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer
Status:
Terminated
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This study will analyze the effects, good and/or bad, of the drug Abraxane in combination
with gemcitabine and gemcitabine with concurrent radiation therapy for patients with locally
advanced pancreatic cancer that cannot be removed by surgery. All of the medications used in
this study are FDA-approved for use in patients with pancreatic cancer.